The incorporation of Pd catalysis in the design of two commercial routes at Pfizer will be discussed. In addition, new developments in Ni catalysis research at Pfizer will be disclosed, with special emphasis on a new, stable Ni(II) precatalyst for high-throughput experimentation applications as an alternative to Ni(COD)2.

Applications of Pd and Ni catalysis to Pfizer’s portfolio

249th National Meeting (2015)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.